High-Throughput Screening Assays

"High-Throughput Screening Assays" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.

Descriptor ID	D057166
MeSH Number(s)	E05.916.680
Concept/Terms	High-Throughput Screening Assays High-Throughput Screening Assays Assay, High-Throughput Screening High Throughput Screening Assays High-Throughput Screening Assay Screening Assay, High-Throughput Screening Assays, High-Throughput High-Throughput Screening Methods High-Throughput Screening Methods High Throughput Screening Methods High-Throughput Screening Method Methods, High-Throughput Screening Screening Method, High-Throughput Screening Methods, High-Throughput High-Throughput Biological Assays High-Throughput Biological Assays Assay, High-Throughput Biological Assays, High-Throughput Biological Biological Assay, High-Throughput Biological Assays, High-Throughput High Throughput Biological Assays High-Throughput Biological Assay High-Throughput Chemical Assays High-Throughput Chemical Assays Assay, High-Throughput Chemical Assays, High-Throughput Chemical Chemical Assay, High-Throughput Chemical Assays, High-Throughput High Throughput Chemical Assays High-Throughput Chemical Assay

Below are MeSH descriptors whose meaning is more general than "High-Throughput Screening Assays".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Technology, Pharmaceutical [E05.916]
High-Throughput Screening Assays [E05.916.680]

Below are MeSH descriptors whose meaning is related to "High-Throughput Screening Assays".

Below are MeSH descriptors whose meaning is more specific than "High-Throughput Screening Assays".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "High-Throughput Screening Assays" by people in this website by year, and whether "High-Throughput Screening Assays" was a major or minor topic of these publications.

Bar chart showing 49 publications over 14 distinct years, with a maximum of 7 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2009	0	1	1
2010	1	1	2
2011	0	3	3
2012	0	3	3
2013	4	2	6
2014	4	2	6
2015	1	0	1
2016	1	6	7
2017	4	1	5
2018	1	1	2
2019	2	3	5
2020	1	1	2
2021	1	3	4
2023	0	2	2

Below are the most recent publications written about "High-Throughput Screening Assays" by people in Profiles.

Peat TJ, Gaikwad SM, Dubois W, Gyabaah-Kessie N, Zhang S, Gorjifard S, Phyo Z, Andres M, Hughitt VK, Simpson RM, Miller MA, Girvin AT, Taylor A, Williams D, D'Antonio N, Zhang Y, Rajagopalan A, Flietner E, Wilson K, Zhang X, Shinn P, Klumpp-Thomas C, McKnight C, Itkin Z, Chen L, Kazandijian D, Zhang J, Michalowski AM, Simmons JK, Keats J, Thomas CJ, Mock BA. Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma. Cancer Lett. 2023 08 01; 568:216284.

View in: PubMed
Ajetunmobi OH, Wall G, Bonifacio BV, Montelongo-Jauregui D, Lopez-Ribot JL. A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput Screening. Methods Mol Biol. 2023; 2658:53-64.

View in: PubMed
Mazzio E, Mack N, Badisa RB, Soliman KFA. Triple Isozyme Lactic Acid Dehydrogenase Inhibition in Fully Viable MDA-MB-231 Cells Induces Cytostatic Effects That Are Not Reversed by Exogenous Lactic Acid. Biomolecules. 2021 11 24; 11(12).

View in: PubMed
Cheng T, Torres NS, Chen P, Srinivasan A, Cardona S, Lee GC, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. A Facile High-Throughput Model of Surface-Independent Staphylococcus aureus Biofilms by Spontaneous Aggregation. mSphere. 2021 04 28; 6(2).

View in: PubMed
Tarpley M, Oladapo HO, Strepay D, Caligan TB, Chdid L, Shehata H, Roques JR, Thomas R, Laudeman CP, Onyenwoke RU, Darr DB, Williams KP. Identification of harmine and ?-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies. Eur J Pharm Sci. 2021 Jul 01; 162:105821.

View in: PubMed
Ju X, Zhu Y, Wang Y, Li J, Zhang J, Gong M, Ren W, Li S, Zhong J, Zhang L, Zhang QC, Zhang R, Ding Q. A novel cell culture system modeling the SARS-CoV-2 life cycle. PLoS Pathog. 2021 03; 17(3):e1009439.

View in: PubMed
Shao Y, Zhang QC. Targeting RNA structures in diseases with small molecules. Essays Biochem. 2020 12 07; 64(6):955-966.

View in: PubMed
Selvam C, Mock CD, Mathew OP, Ranganna K, Thilagavathi R. Discovery of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors by Ligand-based Virtual High Throughput Screening. Mol Inform. 2020 07; 39(7):e1900150.

View in: PubMed
Li P, Shi R, Zhang QC. icSHAPE-pipe: A comprehensive toolkit for icSHAPE data analysis and evaluation. Methods. 2020 06 01; 178:96-103.

View in: PubMed
Blanchard EL, Argyropoulou D, Zurla C, Bhosle SM, Vanover D, Santangelo PJ. Quantification and Localization of Protein-RNA Interactions in Patient-Derived Archival Tumor Tissue. Cancer Res. 2019 10 15; 79(20):5418-5431.

View in: PubMed

People

Explore

Similar Concepts

Top Journals